ApaTech wins third successive TECH TRACK award
21 September 2009
ApaTech, the rapidly growing orthobiologics company, has been recognized for the third successive year as Britain’s fastest growing private medical technology company.
The Sunday Times Microsoft Tech Track 100 awards announced on 20 September 2009 ranked ApaTech 2nd in the top 100, up 3 places on the Company’s position in last year’s awards. The rankings recognise the remarkable sales performance of ApaTech over the four years to March 2009, which have seen revenues grow at a compound annual growth rate of 180%.
ApaTech’s growth is the result of rapid international adoption of Actifuse, the company’s unique silicate substituted calcium phosphate bone graft material. Actifuse scaffold mimics the body’s natural boney structure and accelerates the growth of high quality bone.
ApaTech products are increasingly being adopted worldwide by orthopaedic and neuro-surgeons in spine fusion, joint reconstruction and trauma applications and the company is now selling its products in 33 countries.
Commenting on the award, Simon Cartmell, Chief Executive Officer of ApaTech said: “This award recognises our delivery on the promise of our technology and its huge commercial potential. It is a great tribute to the success of our scientific leadership and the dedication of our people, and to win the award in three successive years makes us very proud.”
Ends
Further Information:
ApaTech +44 20 8731 4640
Simon Cartmell, CEO
simon.cartmell@apatech.com
www.apatech.com
Waughton +44 20 7796 9999
Robin Hepburn
rhepburn@waughton.com
www.waughton.com
Notes to Editors:
About ApaTech
ApaTech specializes in producing synthetic bone repair material. It has operations in London, England, Foxborough, Massachusetts, USA, and Berlin, Germany, and is a world leader in bone graft technologies, selling its products in 33 countries around the world.
The Company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the Company’s leadership in applying the science of silicon to bone graft technologies. The Company believes that Actifuse is the first of a new class of synthetic bone graft materials that combine osteo-conductive and osteo-stimulatory activities that accelerate bone healing.
ApaTech is backed by international investors, DFJ Esprit and Healthcor and was recognized as Britain’s fastest growing medical technology company in both the 2008 and 2007 Sunday Times Tech Track 100 fastest growing private companies review.
More details can be found at www.apatech.com
About Tech Track 100
The annual Tech Track 100 league table was published in The Sunday Times on 20 September 2009 and is supported by the title sponsor Microsoft. The league table is co-sponsored by Barclays Commercial Bank and BDO Stoy Hayward.
Tech Track 100, complied by Fast Track, ranks Britain's fastest-growing private tech companies based on sales growth as measured by compound annual growth rate over three financial years. www.fasttrack.co.uk
« BACK
